Former Senator Ben Sasse Credits 'Miracle Drug' for Extending Life Amid Cancer Battle
Former Republican Senator Ben Sasse has publicly discussed his battle with stage 4 pancreatic cancer and the role of a 'miracle drug' in extending his life. Sasse, who was initially given a prognosis of three to four months to live, credits the experimental drug daraxonrasib, currently under FDA review, for significantly reducing his tumor volume and alleviating pain. The drug, part of a clinical trial, targets a common gene mutation in pancreatic cancer, offering a potentially less toxic alternative to chemotherapy. 
